부산대학교 도서관

Grivas P; Division of Hematology/Oncology, Department of Medicine, University of Washington, Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Garralda E; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Meric-Bernstam F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Mellinghoff IK; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Goyal L; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.; Harding JJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York.; Dees EC; Lineberger Comprehensive Cancer Center and Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Bahleda R; Drug Development Department, Institut Gustave Roussy, Villejuif, France.; Azad NS; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Karippot A; Cancer Treatment Centers of America, Tulsa, Oklahoma.; Kurzrock R; Center for Personalized Cancer Therapy, University of California San Diego, Moores Cancer Center, La Jolla, California.; Tabernero J; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Kononen J; Docrates Cancer Center, Helsinki, Finland.; Ng MCH; Division of Medical Oncology, National Cancer Centre, Singapore, Singapore.; Mehta R; GI Medical Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.; Uboha NV; Division of Hematology and Oncology, Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin.; Bigot F; Medical Oncology Department, Institut de Cancérologie de l'Ouest, Angers, France.; Boni V; START Madrid, Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain.; Bowyer SE; Linear Clinical Research, Perth, Australia.; Breder V; NN Blokhin National Medical Research Center of Oncology, Ministry of Health, Moscow, Russian Federation.; Cervantes A; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Chan N; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.; Cleary JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Dhawan M; Division of Hematology and Oncology, University of California, San Francisco, California.; Eefsen RL; Department of Oncology, Herlev Gentofte Hospital, Herlev, Denmark.; Ewing J; Ironwood Cancer and Research Centers, Scottsdale, Arizona.; Graham DM; The Christie NHS Foundation Trust, Manchester, United Kingdom.; Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.; Guren TK; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Won Kim J; Division of Hematology/Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea.; Koynov K; Department of Medical Oncology, MHAT 'Serdika', Sofia, Bulgaria.; Oh DY; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, South Korea.; Redman R; Brown Cancer Center, University of Louisville, Louisville, Kentucky.; Yen CJ; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Spetzler D; Caris Life Sciences, Phoenix, Arizona.; Roubaudi-Fraschini MC; Debiopharm International, Lausanne, Switzerland.; Nicolas-Metral V; Debiopharm International, Lausanne, Switzerland.; Ait-Sarkouh R; Debiopharm International, Lausanne, Switzerland.; Zanna C; Debiopharm International, Lausanne, Switzerland.; Ennaji A; Debiopharm International, Lausanne, Switzerland.; Pokorska-Bocci A; Debiopharm International, Lausanne, Switzerland.; Flaherty KT; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE